###begin article-title 0
Separation of Anti-Proliferation and Anti-Apoptotic Functions of Retinoblastoma Protein through Targeted Mutations of Its A/B Domain
###end article-title 0
###begin p 1
Conceived and designed the experiments: JW BC. Performed the experiments: BC CP. Analyzed the data: JW BC. Wrote the paper: JW.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human retinoblastoma susceptibility gene encodes a nuclear phosphoprotein RB, which is a negative regulator of cell proliferation. The growth suppression function of RB requires an evolutionarily conserved A/B domain that contains two distinct peptide-binding pockets. At the A/B interface is a binding site for the C-terminal trans-activation domain of E2F. Within the B-domain is a binding site for proteins containing the LxCxE peptide motif.
###end p 3
###begin title 4
Methodology/Principle Findings
###end title 4
###begin p 5
Based on the crystal structure of the A/B domain, we have constructed an RB-K530A/N757F (KN) mutant to disrupt the E2F- and LxCxE-binding pockets. The RB-K530A (K) mutant is sufficient to inactivate the E2F-binding pocket, whereas the RB-N757F (N) mutant is sufficient to inactivate the LxCxE-binding pocket. Each single mutant inhibits cell proliferation, but the RB-KN double mutant is defective in growth suppression. Nevertheless, the RB-KN mutant is capable of reducing etoposide-induced apoptosis.
###end p 5
###begin title 6
Conclusion/Significance
###end title 6
###begin p 7
Previous studies have established that RB-dependent G1-arrest can confer resistance to DNA damage-induced apoptosis. Results from this study demonstrate that RB can also inhibit apoptosis independent of growth suppression.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RB1</italic>
###xml 113 116 113 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Hanahan1">[1]</xref>
###xml 142 145 142 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RB1</italic>
###xml 270 273 270 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RB1</italic>
###xml 316 319 316 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RB1</italic>
###xml 327 330 327 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Dryja1">[2]</xref>
###xml 332 335 332 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Cavenee1">[3]</xref>
###xml 373 376 373 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RB1</italic>
###xml 694 697 694 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Hanahan1">[1]</xref>
###xml 878 881 878 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-DeGregori1">[4]</xref>
###xml 983 986 983 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-DeGregori1">[4]</xref>
###xml 1079 1082 1079 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Bracken1">[5]</xref>
###xml 200 208 <span type="species:ncbi:9606">children</span>
###xml 417 422 <span type="species:ncbi:9606">human</span>
The retinoblastoma susceptibility gene (RB1) encodes a nuclear phosphoprotein RB with tumor suppression function [1]. Inheritance of germline RB1 mutation causes retinoblastoma with 90% penetrance in children; the tumor cells exhibit loss of heterozygosity (LOH) at the RB1 locus with the invariable loss the normal RB1 allele [2], [3]. The bi-alleleic inactivation of the RB1 gene has also been detected in sporadic human cancers of a variety of tissue origins at an average frequency of approximately 10% (COSMIC database at the Sanger Genome Center). The current knowledge suggests that RB suppresses tumor development by inhibiting cell proliferation and promoting terminal differentiation [1]. The anti-proliferation function of RB is dependent on its interaction with the cellular E2F-family transcription factors, which are heterodimers consisting of E2F and DP subunits [4]. RB directly interacts with several members of the E2F family to inhibit E2F-dependent transcription [4]. The E2F transcription factors regulate genes required for cell proliferation and apoptosis [5]. By inhibiting E2F-dependent transcription, RB negatively regulates cell proliferation and apoptosis.
###end p 9
###begin p 10
###xml 273 276 273 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Lee1">[6]</xref>
###xml 278 281 278 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Xiao1">[7]</xref>
###xml 404 407 404 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Xiao1">[7]</xref>
###xml 563 566 563 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Lee1">[6]</xref>
###xml 689 692 689 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Chen1">[8]</xref>
###xml 693 697 693 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Dick2">[10]</xref>
###xml 137 142 <span type="species:ncbi:9606">human</span>
The growth suppression function of RB protein requires its A/B domain that is conserved in the RB-family proteins. The A/B domain of the human RB protein contains at least two distinct peptide-binding pockets, whose structures have been elucidated by X-ray crystallography [6], [7]. The E2F-peptide binding pocket resides at the A/B domain interface, which binds the C-terminal peptide of E2F-1, 2, and 3[7]. The LxCxE-peptide binding pocket is a shallow groove within the B-domain, which mediates the interaction with proteins containing the LxCxE peptide motif [6]. The two distinct peptide-binding pockets in the A/B domain have each been inactivated by targeted substitution mutations [8]-[10].
###end p 10
###begin p 11
###xml 177 180 177 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Chen1">[8]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Dick2">[10]</xref>
###xml 319 322 319 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Chen1">[8]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Dick2">[10]</xref>
###xml 517 520 517 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Chen1">[8]</xref>
###xml 631 634 631 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Chen1">[8]</xref>
###xml 111 115 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Disruption of the LxCxE-binding pocket abrogates the interaction between RB and viral oncoproteins such as the SV40 T-antigen, the HPV E7 protein and the adenovirus E1A protein [8], [10]. The LxCxE-binding-defective RB mutants retain growth suppression function because these mutants retain their interactions with E2F [8], [10]. One of the LxCxE binding-defective mutants constructed by our lab contains a single substitution mutation of Asn757 (RB-N, N757F), which is sufficient to disrupt the LxCxE-binding pocket [8]. This RB-N mutant represses E2F-dependent transcription, inhibits DNA synthesis, and reduces colony formation [8]. As reported here, we have since disrupted the E2F peptide-binding pocket at the RB A/B interface by mutating Lys530 with Ala (RB-K, K530A). The RB-K mutant also remains competent in inhibiting cell proliferation. However, the RB-KN double mutant does not induce growth arrest.
###end p 11
###begin p 12
###xml 125 127 125 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Knudsen1">[11]</xref>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Harrington1">[12]</xref>
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-HaasKogan1">[13]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Angus1">[14]</xref>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Masselli1">[15]</xref>
###xml 744 747 744 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Bracken1">[5]</xref>
Previous studies have demonstrated that RB-dependent growth arrest is protective against apoptosis. Fibroblasts derived from Rb-null embryos are defective in DNA damage-induced G1, S and G2 arrest and exhibit increased apoptotic response to genotoxins [11], [12]. The ectopic expression of RB in SAOS-2 osteosarcoma cells induces G1 arrest and protects from apoptosis induced by ionizing radiation [13]. Induced expression of a constitutively active RB that lacks nine phosphorylate sites (PSM-RB) interfered with doxorubicin-induced activation of caspase-3 as a consequence of G1-arrest [14], [15]. The apoptosis resistance of G1-arrested cells is likely to involve RB-dependent transcriptional repression of E2F-regulated pro-apoptotic genes [5]. Therefore, the anti-apoptotic activity of RB has mostly been considered as a secondary effect of its growth suppression function. In this study, we show that RB and RB-KN can inhibit apoptosis without causing cell cycle arrest. We have demonstrated that RB-KN is a separation of function mutant, which is useful in further studies of the anti-apoptotic function of RB.
###end p 12
###begin title 13
Materials and Methods
###end title 13
###begin title 14
Cell culture and plasmid construction
###end title 14
###begin p 15
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 262 267 <span type="species:ncbi:9606">human</span>
Human breast adenocarcinoma MDA-MB468 and osteosarcoma SAOS-2 cells were maintained in DMEM supplemented with 10%FBS. Transfections were performed with Fugene (Roche Diagnostics) as per manufacturer's instructions. K530A and N757F mutations were introduced into human RB cDNA via PCR-mediated mutagenesis and the resulting mutation confirmed by DNA sequencing.
###end p 15
###begin title 16
GST pull-down, co-immunoprecipitation and immunoblotting
###end title 16
###begin p 17
###xml 298 301 298 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Chen1">[8]</xref>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Whitaker1">[16]</xref>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Kaelin1">[17]</xref>
###xml 833 837 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Welch1">[18]</xref>
###xml 1105 1106 1105 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 108 113 <span type="species:ncbi:9606">human</span>
###xml 134 139 <span type="species:ncbi:9606">human</span>
###xml 162 167 <span type="species:ncbi:9606">human</span>
###xml 824 829 <span type="species:ncbi:9606">human</span>
GST fusion proteins of RB (human, containing amino acids 395 through 928), E2F1 (human, full-length), E2F3 (human, full-length), DP1 (human, full-length) and E7 (human papilloma virus-16, full-length) were expressed in bacteria and purified on Glutathione Sepharose (Pharmacia) by standard methods [8], [16], [17]. The GST fusion proteins were mixed with cell lysates in binding buffer (25 mM Tris-HCl, pH7.5, 250mM KCl, 0.1% Triton X-100, 0.5 mM EDTA, 0.1 mM DTT) and protease inhibitors (Sigma). After extensive washing in the same binding buffer, proteins retained on the solid phase were eluted by the addition of SDS sample buffer and subjected to SDS-PAGE for fractionation prior to being transferred onto PVDF membrane. RB protein on the blot was detected with an affinity-purified polyclonal antibody raised against human RB [18]. HA-tagged proteins of E2F1/3 were detected with an anti-HA monoclonal antibody (Clone HA.11) obtained from Berkeley Antibody Co. E2F1 (KH95) and cleaved caspase-3 (D175) antibodies were obtained from Santa Cruz and Cell Signaling Technology respectively. Cytochrome c antibody was obtained from Pharmingen. For co-immunoprecipitation, cells were lysed in the binding buffer, the lysates clarified by centrifugation, and then incubated with anti-RB or anti-HA. The immune complexes were collected on protein G Sepharose, solubilized with SDS sample buffer for immunoblotting by standard methods.
###end p 17
###begin title 18
Adenovirus infection
###end title 18
###begin p 19
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-He1">[19]</xref>
Recombinant adenovirus was constructed and amplified using the AdEasy system [19]. Cells were infected at a multiplicity of 100 overnight prior to treatment with etoposide.
###end p 19
###begin title 20
Flat cell formation and BrdU incorporation
###end title 20
###begin p 21
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Whitaker1">[16]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Welch1">[18]</xref>
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Whitaker1">[16]</xref>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Templeton1">[20]</xref>
SAOS-2 cells were transfected with plasmids encoding RB, RB-K, RB-N or RB-KN and the neomycin resistance gene [16], [18]. The transfected cells were selected with G418 for 14 days, stained with crystal violet, and the giant flat cells counted under a dissection microscope (5x magnification) [16], [20]. Cells were incubated with 10 mM BrdU for 14 hours, fixed, and stained with phycoerythrin-conjugated monoclonal antibody against BrdU (BrdU-PE). The percentage of BrdU-positive fraction was determined by FACS analysis. To determine the non-specific background signal, we carried out FACS analyses using cells that were stained with the PE-conjugated IgG. The BrDU-positive fraction was determined using a gate that excluded the background signal.
###end p 21
###begin title 22
Apoptosis assays
###end title 22
###begin p 23
###xml 36 37 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
To measure the extent of cytochrome c release from mitochondria, cells were harvested and resuspended in Mitobuffer (20 mM HEPES (pH 7.5), 1 mM EGTA, 1 mM EDTA, 10 mM KCl, 1.5 mM MgCl2, 1 mM DTT, 0.1 mM PMSF, 2 microg/ml Leupeptin, 2 microg/ml Pepstatin, 2 microg/ml Aprotinin) and then mechanically ruptured with 25 strokes of pestle in a glass homogenizer placed on ice. The lysates were spun free of nuclei and intact cells at a speed of 500xg. The supernatant was then subjected to centrifugation at 8,000xg to pellet mitochondria. To measure the sub-G1 DNA content, cells were fixed in ice-cold ethanol (70%), re-suspended in phosphate buffered saline containing 40 microg/ml RNase and 20 microg/ml propidium iodide and then subjected to FACS analyses.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
K530A mutation abrogates RB interaction with the trans-activation domain of E2F
###end title 25
###begin p 26
###xml 107 110 107 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Xiao1">[7]</xref>
###xml 319 326 319 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1A</xref>
###xml 377 386 377 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1B&#8211;E</xref>
###xml 517 524 517 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1A</xref>
###xml 526 529 526 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Chen1">[8]</xref>
The structure of RB A/B domain in complex with the C-terminal E2F peptide (aa 409-426) has been determined [7]. Based on the atomic interactions between RB and E2F amino acids, we constructed several mutations to disrupt this E2F-binding pocket. Among the mutants, Lys530Ala substitution in the A-domain (K530A, RB-K) (Fig. 1A) is sufficient to disrupt the RB-E2F interaction (Fig. 1B-E). We have previously inactivated the LxCxE-binding pocket with the Asn757Phe substitution mutation (N757F, RB-N) in the B-domain (Fig. 1A) [8]. The RB-KN mutant contains both point mutations.
###end p 26
###begin p 27
###xml 309 316 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1B</xref>
###xml 445 452 445 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1B</xref>
###xml 600 607 600 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1B</xref>
###xml 779 786 779 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1B</xref>
###xml 904 911 904 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1C</xref>
###xml 913 917 913 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Phillips1">[21]</xref>
###xml 1158 1165 1158 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1C</xref>
The RB and mutant proteins were expressed in the RB-deficient breast cancer cell line MBA-MD468 through adenoviral-mediated gene transfer, and lysates from the adenovirus-infected cells were then applied to glutathione-agarose beads loaded with GST-E2F1 or GST-E7 recombinant proteins purified from bacteria (Fig. 1B). As we have previously reported, GST-E2F1 could pull down RB and RB-N, whereas GST-E7 efficiently pulled down RB but not RB-N (Fig. 1B). In contrast, the RB-K mutant was efficiently pulled down by GST-E7, demonstrating the integrity of the LxCxE-binding pocket in the RB-K protein (Fig. 1B). However, GST-E2F1 did not pull down RB-K, suggesting a critical role of K530 in binding E2F1. As would be expected, the RB-KN was not pulled down by GST-E2F1 or GST-E7 (Fig. 1B). In a reversed GST-pull down experiment, E2F-1 expression was induced in a tetracycline-sensitive SAOS-2 cell line (Fig. 1C) [21]. Cell lysates with overproduced E2F-1 was applied to glutathione beads containing GST-RB or GST-RB-K recombinant proteins expressed in bacteria. The pull-down of E2F1 by GST-RB-K was significantly reduced when compared with that by GST-RB (Fig. 1C).
###end p 27
###begin p 28
###xml 87 94 87 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1D</xref>
###xml 126 133 126 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1E</xref>
###xml 312 319 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1D</xref>
###xml 379 399 379 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1D, lower panel</xref>
###xml 497 516 497 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig 1D, upper panel</xref>
###xml 613 634 613 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1D, middle panel</xref>
###xml 766 770 766 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Flemington1">[22]</xref>
###xml 772 776 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Ross1">[23]</xref>
###xml 965 969 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Flemington1">[22]</xref>
###xml 1079 1086 1079 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1E</xref>
The defect of RB-K in binding E2F1 was further demonstrated by co-immunoprecipitation (Fig. 1D) and transcription-repression (Fig. 1E). The E2F1-inducible SAOS-2 cells were infected with adenovirus expressing GFP, RB, RB-K, RB-N or RB-KN, followed by the induction of E2F-1 and immunoprecipitation with anti-RB (Fig. 1D). Each of the RB proteins was expressed to similar levels (Fig. 1D, lower panel). The induction of E2F-1 was also similar among the different cultures of infected SAOS-2 cells (Fig 1D, upper panel). The co-immunoprecipitation of E2F-1 was observed with RB and RB-N but not with RB-K or RB-KN (Fig. 1D, middle panel). The C-terminal region of E2F1 is required for its transcriptional activation function, which is inhibited upon the binding of RB [22], [23]. To measure this trans-activation function of E2F1, a Gal4-E2F1 fusion protein was used to drive the expression of a luciferase reporter under the control of tandem Gal4 DNA binding sites [22]. With this well-established co-transfection assay, Gal4-E2F1 stimulated the reporter expression by 300 fold (Fig. 1E). RB reduced the Gal4-E2F1 activity by 3 fold, whereas RB-K did not affect the Gal4-E2F1 activity consistent with the defective binding. Taken together, these results are consistent with the X-ray crystal structure and support the importance of Lysine-530 in the interaction between RB and the C-terminal peptide in E2F1.
###end p 28
###begin title 29
RB-K530A binds to E2F1-DP1
###end title 29
###begin p 30
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Ross1">[23]</xref>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Ross1">[23]</xref>
###xml 409 416 409 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1E</xref>
###xml 496 503 496 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g002">Fig. 2A</xref>
###xml 544 552 544 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyclin A</italic>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Strobeck1">[24]</xref>
###xml 698 706 698 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyclin A</italic>
###xml 802 809 802 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g002">Fig. 2A</xref>
###xml 915 923 915 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyclin A</italic>
It is well established that RB can inhibit E2F-dependent transcription through two mechanisms. RB binds the C-terminal trans-activation domain of E2F1 to inhibit transcription [23]. The RB-E2F complex also interacts with other transcription co-repressors such as histone deacetylases or methylases to inhibit transcription [23]. Although RB-K is defective in inhibiting the trans-activation activity of E2F1 (Fig. 1E), it was competent in repressing transcription from an E2F-regulated promoter (Fig. 2A). Previous studies have established the Cyclin A promoter to contain E2F-binding site and the promoter activity is repressed by the RB-E2F complex [24]. With a luciferase reporter driven by the Cyclin A promoter, it can be shown that RB, RB-K and RB-N are each capable of transcription repression (Fig. 2A). The RB-mediated repression was dependent on E2F, because mutations of the E2F-binding sequences in the Cyclin A promoter abolished the RB-mediated transcription repression (not shown). These results suggest that RB-K can still interact with E2F, although not through binding to the E2F C-terminal region.
###end p 30
###begin p 31
###xml 100 103 100 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Dick1">[9]</xref>
###xml 375 382 375 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g002">Fig. 2B</xref>
###xml 569 576 569 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1C</xref>
###xml 782 789 782 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g002">Fig. 2C</xref>
###xml 907 914 907 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g002">Fig. 2C</xref>
###xml 949 956 949 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g001">Fig. 1D</xref>
###xml 1083 1086 1083 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Dick1">[9]</xref>
###xml 1247 1254 1247 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g002">Fig. 2D</xref>
It has been reported that the RB C-region contains a second binding site for the E2F/DP heterodimer [9]. We therefore determined if RB-K retained the ability to interact with E2F/DP1. A HA-tagged E2F1 was co-expressed with DP1 in 293T cells, and the cell lysates were then incubated with five different GST-fusion proteins- GST-E7, GST-RB, GST-RB-K, GST-RB-N, and GST-RB-KN (Fig. 2B). Under conditions of E2F1 and DP1 co-expression, we found that each of the GST-RB fusion protein were capable of efficient pull down of E2F1. This is in contrast to the result shown in Fig. 1C, when E2F1 was expressed alone without DP1. We also performed co-immunoprecipitation experiments where HA-E2F1, DP1, and RB were transiently co-expressed in the RB-deficient C33A cervical carcinoma cells (Fig. 2C). The interaction between RB, RB-K and RB-KN with E2F1 was consistently observed in independently transfected cells (Fig. 2C), contrasting the result shown in Fig. 1D. It has been reported that the RB C-region preferentially binds E2F1/DP1 and exhibits a much weaker interaction with E2F3/DP1 [9]. When RB, E2F3 and DP1 were transiently co-expressed in 293 cells, we found E2F3 to co-immunoprecipitate with RB but the interaction was much weaker with RB-K (Fig. 2D). This result is consistent with previous reports that RB interacts with E2F3 mostly through its E2F-peptide binding pocket at the A/B interface that is inactivated by the K530A mutation.
###end p 31
###begin title 32
RB-KN lacks growth suppression activity
###end title 32
###begin p 33
###xml 292 299 292 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g003">Fig. 3A</xref>
###xml 438 445 438 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g003">Fig. 3A</xref>
###xml 585 592 585 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g003">Fig. 3A</xref>
We next measured the growth suppression activity of RB mutants by a short-term assay of BrdU-incorporation and a long-term assay of flat cell formation. In the short-term assay, MDA-MB468 cells were infected with adenovirus expressing GFP, RB, RB-K, RB-N or RB-KN and then labeled with BrdU (Fig. 3A). Relative to cells infected with the control GFP-virus, cells infected with RB-, RB-K-, or RB-N-virus showed reduced BrdU incorporation (Fig. 3A). Cells infected with RB-KN, on the other hand, incorporated BrdU to a level that was indistinguishable from the GFP-virus infected cells (Fig. 3A).
###end p 33
###begin p 34
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Templeton1">[20]</xref>
###xml 633 640 633 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g003">Fig. 3B</xref>
###xml 820 827 820 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g003">Fig. 3B</xref>
###xml 1435 1443 1435 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyclin A</italic>
###xml 1454 1461 1454 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g002">Fig. 2A</xref>
###xml 103 108 <span type="species:ncbi:9606">human</span>
In the long-term assay, we used the well-established induction of senescence by RB in the RB-deficient human SAOS-2 cells. Ectopic expression of RB induces the formation of large flat cells that are metabolically active but do not undergo cell division [20]. In RB-transfected cultures, the flat cell numbers ranged from 200-400 per plate in four independent experiments. In mock- transfected cultures, 0-4 flat cells were found per plate. In RB-N-transfected cultures, 120-220 flat cells were found, and in RB-K-transfected cells, 80-170 flat cells were counted. The relative flat cell counts from the four experiments are shown in Fig. 3B. Only 10-20 flat cells were found in cultures transfected with the RB-KN mutant, showing a statistically significant reduction in the flat-cell induction activity of this mutant (Fig. 3B). Because the levels of protein expression through adenovirus infection were higher than those from DNA transfection, we also compared the effect of RB mutants on BrdU incorporation in transfected SAOS-2 cells. The result was consistent with the flat cell assay: inhibition of BrdU incorporation by RB-K was less efficient than by RB, whereas RB-KN did not inhibit BrdU incorporation (not shown). These results show that the RB-K or the RB-N mutant retains growth suppression activity, but the RB-KN mutant is defective in growth suppression, consistent with its defect in repressing transcription from the Cyclin A promoter (Fig. 2A).
###end p 34
###begin title 35
RB-KN inhibits apoptosis
###end title 35
###begin p 36
Because RB-KN is defective in growth suppression, this mutant provides an opportunity to test the hypothesis that the anti-apoptotic function of RB is secondary to growth arrest.
###end p 36
###begin p 37
###xml 238 245 238 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g004">Fig. 4A</xref>
###xml 259 260 259 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 270 277 270 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g004">Fig. 4C</xref>
###xml 315 322 315 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g004">Fig. 4D</xref>
###xml 462 469 462 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g004">Fig. 4A</xref>
###xml 598 605 598 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g004">Fig. 4A</xref>
###xml 822 829 822 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g004">Fig. 4A</xref>
###xml 878 885 878 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g003">Fig. 3A</xref>
The RB-deficient MDA-MB468 breast cancer cells were infected with adenovirus expressing GFP, RB, RB-K, RB-N, or RB-KN. The infected cells were then treated with etoposide. Apoptosis was assessed by DNA fragmentation (sub-G1 DNA content) (Fig. 4A), cytochrome c release (Fig. 4C), and the cleavage of pro-caspase 3 (Fig. 4D). Etoposide treatment led to a significant increase in DNA fragmentation (assessed by the sub-G1 DNA content) in GFP-virus infected cells (Fig. 4A). The increase in sub-G1 DNA content was negligible in etoposide-treated cells that were infected with RB, RB-K, or RB-N virus (Fig. 4A). This result supports the conclusion that RB-mediated growth arrest confers resistant to genotoxin-induced apoptosis. Interestingly, however, the RB-KN-virus infected cells also displayed reduced DNA fragmentation (Fig. 4A), despite the continued cell cycle progression (Fig. 3A).
###end p 37
###begin p 38
###xml 41 42 41 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 80 87 80 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g004">Fig. 4C</xref>
###xml 216 223 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g004">Fig. 4C</xref>
###xml 335 342 335 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g004">Fig. 4D</xref>
###xml 430 437 430 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g004">Fig. 4D</xref>
###xml 513 520 513 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g004">Fig. 4B</xref>
Exposure to etoposide induced cytochrome c release in GFP-virus infected cells (Fig. 4C). Activation of this critical step in the intrinsic apoptotic pathway by etoposide was reduced in cells expressing RB or RB-KN (Fig. 4C). The etoposide-induced cleavage of pro-caspase-3 was reduced in MDA-MB438 cells expressing RB, RB-K, or RB-N (Fig. 4D). This proteolytic processing of caspase-3 was also reduced in cells expressing RB-KN (Fig. 4D). The anti-apoptotic effect of RB-KN was observed in SAOS-2 cells as well (Fig. 4B), showing that RB-KN could inhibit apoptosis without suppressing cell growth in two different RB-deficient cell lines.
###end p 38
###begin title 39
RB retains anti-apoptotic function in proliferating cells
###end title 39
###begin p 40
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Hinds1">[25]</xref>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Knudsen2">[26]</xref>
###xml 445 452 445 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g005">Fig. 5A</xref>
To determine whether wild type RB has anti-apoptotic function in proliferating cells, we took note of the results that RB-mediated growth arrest can be overridden by the co-expression of cyclins [25], [26]. We therefore co-infected SAOS-2 cells with adenovirus expressing RB and Cdk2/Cyclin E. As would be expected, co-expression of RB with Cdk2/Cyclin E led to RB phosphorylation, indicated by the altered electrophoresis mobility in SDS-PAGE (Fig. 5A).
###end p 40
###begin p 41
###xml 244 255 244 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g005">Fig. 5B &amp; C</xref>
###xml 381 392 381 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g005">Fig. 5B, #1</xref>
###xml 510 521 510 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g005">Fig. 5B, #5</xref>
###xml 531 542 531 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g005">Fig. 5B, #2</xref>
###xml 554 561 554 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g005">Fig. 5C</xref>
###xml 655 673 655 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g005">Fig. 5B, #3 and #4</xref>
###xml 676 683 676 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g005">Fig. 5C</xref>
###xml 799 810 799 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g005">Fig. 5B, #6</xref>
###xml 873 880 873 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g005">Fig. 5C</xref>
###xml 1027 1038 1027 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g005">Fig. 5B, #7</xref>
###xml 1043 1050 1043 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0000082-g005">Fig. 5C</xref>
SAOS-2 cells were infected with adenovirus expressing GFP, RB or RB-KN alone, or in combination with adenovirus expressing Cdk2/Cyclin E. Infected cells were then exposed to etoposide, harvested 48 hours later for FACS analyses of DNA content (Fig. 5B & C). The expression of Cdk2/Cyclin E with GFP caused an increase in the S-phase DNA content, but not an increase in sub-G1 DNA (Fig. 5B, #1). Etoposide-induced increase in sub-G1 DNA content was similar in GFP-expressing cells that expressed Cdk2/Cyclin E (Fig. 5B, #5) or not (Fig. 5B, #2) (see also Fig. 5C). Expression of RB or RB-KN protected SAOS-2 cells from etoposide-induced DNA fragmentation (Fig. 5B, #3 and #4) (Fig. 5C). Co-expression with Cdk2/Cyclin E increased the S-phase fraction of etoposide-treated, RB-positive, SAOS-2 cells (Fig. 5B, #6); yet, it did not override the anti-apoptotic function of RB (Fig. 5C). Co-expression with Cdk2/Cyclin E did not affect either the S-phase or the sub-G1 fraction of etoposide treated, RB-KN-expressing, SAOS-2 cells (Fig. 5B, #7 and Fig. 5C). These results suggest wild-type RB can also reduce apoptosis under condition in which its growth suppression function is impaired.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 119 122 119 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-DeGregori1">[4]</xref>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Chau1">[27]</xref>
###xml 363 366 363 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-DeGregori1">[4]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Ross1">[23]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Chau1">[27]</xref>
###xml 618 621 618 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Dick1">[9]</xref>
###xml 687 691 687 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Rubin1">[28]</xref>
###xml 799 802 799 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Chen1">[8]</xref>
The anti-proliferation function of RB is mediated by the repression of E2F-dependent transcription of cell cycle genes [4], [27]. RB can inhibit E2F-dependent transcription by two mechanisms: either through the direct binding to the C-terminal trans-activation domain of E2F or through the assembly of transcription repressor complexes at E2F-regulated promoters [4], [23], [27]. The RB-K mutant does not bind to the C-terminal trans-activation domain of E2F and it does not inhibit the trans-activation function of E2F1. However, RB-K still interacts with E2F1/DP1, most likely via the C-terminal E2F/DP-binding site [9], of which the X-ray crystal structure has recently been reported [28]. The RB-N mutant retains both E2F-binding pockets, i.e., at the A/B interface and at the C-terminal region [8], accounting for its ability to inhibit cell proliferation. Because the RB-KN double mutant is defective in transcription repression, we can conclude that an intact LxCxE-binding pocket is required for RB-K to repress transcription. Our findings suggest RB-K may inhibit proliferation through the assembly of transcription repression complexes, whereas RB-N is likely to directly inhibit the trans-activation function of E2F. It thus appears that either of the two established transcriptional repression mechanisms is sufficient for RB to inhibit cell proliferation.
###end p 43
###begin p 44
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Knudsen1">[11]</xref>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-HaasKogan1">[13]</xref>
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Chau1">[27]</xref>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Masselli1">[15]</xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Chau1">[27]</xref>
###xml 867 875 867 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyclin A</italic>
###xml 1078 1082 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Wang1">[29]</xref>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Wang2">[30]</xref>
###xml 1189 1193 1189 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Knudsen3">[31]</xref>
###xml 1195 1199 1195 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Knudsen4">[32]</xref>
###xml 1391 1395 1391 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Xiao2">[33]</xref>
###xml 1397 1401 1397 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Goodrich1">[34]</xref>
Previous studies have shown that RB-deficient cells are hypersensitive to DNA damage-induced apoptosis, and that expression of wild-type RB in RB-deficient cells can rescue this hypersensitivity [11], [13], [27]. Furthermore, induced expression of a phosphorylation-site-mutated PSM-RB causes G1 arrest to protect cells from DNA damage-induced apoptosis [15]. The coordinated suppression of proliferation and apoptosis by RB can be explained by its inhibition of E2F-dependent transcription [27]. This study of the RB-K, RB-N and RB-KN mutants, however, has shown that RB can also inhibit apoptosis in proliferating cells. At present, we do not understand the mechanism through which RB-KN inhibits etoposide-induced apoptosis. RB-KN retains the C-terminal E2F1/DP binding site, and may conceivably inhibit a subset of E2F1/DP-regulated promoters (other than that of Cyclin A) to inhibit apoptosis. Alternatively, RB-KN may sequester pro-apoptotic factors other than E2F1, for example, the nuclear ABL tyrosine kinase that has been shown to promote DNA damage-induced apoptosis [29], [30]. Because RB-E2F1 and RB-ABL interactions are disrupted by RB-phosphorylation in proliferating cells [31], [32], the anti-apoptotic activity associated with phosphorylated RB or RB-KN may not be accounted for by the inhibition of E2F-1 and ABL. A recent study has shown that RB can stimulate DNA repair [33], [34], which will enhance cell survival under conditions of genotoxic stress. The RB-KN mutant should facilitate future studies to elucidate the growth suppression-independent anti-apoptotic function of RB.
###end p 44
###begin p 45
We thank Dr. James DeGregori at the University of Colorado, Denver, for the generous gift of recombinant adenovirus expressing Cdk2/Cyclin E.
###end p 45
###begin title 46
References
###end title 46
###begin article-title 47
The hallmarks of cancer.
###end article-title 47
###begin article-title 48
Homozygosity of chromosome 13 in retinoblastoma.
###end article-title 48
###begin article-title 49
###xml 84 89 <span type="species:ncbi:9606">human</span>
Isolation and regional localization of DNA segments revealing polymorphic loci from human chromosome 13.
###end article-title 49
###begin article-title 50
The genetics of the E2F family of transcription factors: shared functions and unique roles.
###end article-title 50
###begin article-title 51
E2F target genes: unraveling the biology.
###end article-title 51
###begin article-title 52
Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7.
###end article-title 52
###begin article-title 53
Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation.
###end article-title 53
###begin article-title 54
Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function.
###end article-title 54
###begin article-title 55
pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities.
###end article-title 55
###begin article-title 56
Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
###end article-title 56
###begin article-title 57
RB-dependent S-phase response to DNA damage.
###end article-title 57
###begin article-title 58
pRB plays an essential role in cell cycle arrest induced by DNA damage.
###end article-title 58
###begin article-title 59
Inhibition of apoptosis by the retinoblastoma gene product.
###end article-title 59
###begin article-title 60
Active RB elicits late G1/S inhibition.
###end article-title 60
###begin article-title 61
Phosphorylation site mutated RB exerts contrasting effects on apoptotic response to different stimuli.
###end article-title 61
###begin article-title 62
Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket.
###end article-title 62
###begin article-title 63
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.
###end article-title 63
###begin article-title 64
A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.
###end article-title 64
###begin article-title 65
A simplified system for generating recombinant adenoviruses.
###end article-title 65
###begin article-title 66
Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering.
###end article-title 66
###begin article-title 67
E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways.
###end article-title 67
###begin article-title 68
E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
###end article-title 68
###begin article-title 69
Active repression and E2F inhibition by pRB are biochemically distinguishable.
###end article-title 69
###begin article-title 70
BRG-1 is required for RB-mediated cell cycle arrest.
###end article-title 70
###begin article-title 71
###xml 72 77 <span type="species:ncbi:9606">human</span>
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.
###end article-title 71
###begin article-title 72
Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression.
###end article-title 72
###begin article-title 73
Coordinated regulation of life and death by RB.
###end article-title 73
###begin article-title 74
Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
###end article-title 74
###begin article-title 75
Regulation of cell death by the Abl tyrosine kinase.
###end article-title 75
###begin article-title 76
Nucleo-cytoplasmic communication in apoptotic response to genotoxic and inflammatory stress.
###end article-title 76
###begin article-title 77
Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites.
###end article-title 77
###begin article-title 78
Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.
###end article-title 78
###begin article-title 79
The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes.
###end article-title 79
###begin article-title 80
The retinoblastoma tumor-suppressor gene, the exception that proves the rule.
###end article-title 80
###begin title 81
Figures and Tables
###end title 81
###begin title 82
A) Summary of RB mutants.
###end title 82
###begin p 83
###xml 40 45 <span type="species:ncbi:9606">human</span>
The amino acid numbering is that of the human retinoblastoma protein.
###end p 83
###begin p 84
Two shaded boxes represent the A and B domains; I, the insert region; N, the region N-terminal to the A domain; C, the region C-terminal to the B domain.
###end p 84
###begin p 85
B) GST pull-down assay.
###end p 85
###begin p 86
The RB-deficient MDA-MB468 cells were infected with recombinant adenovirus encoding GFP, RB, RB-K, RB-N or RB-KN, whole cell lysates were incubated with purified GST-E2F1 or GST-E7 fusion protein immobilized on glutathione-Sepharose.
###end p 86
###begin p 87
The bound fractions were solubilized, fractionated by SDS-PAGE and reacted with an affinity-purified anti-RB.
###end p 87
###begin p 88
C) Reciprocal GST pull-down assay.
###end p 88
###begin p 89
###xml 35 39 35 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Phillips1">[21]</xref>
Lysates from SAOS-2-tet-E2F1 cells [21] were immunoblotted with anti-E2F1 to demonstrate the induced expression of E2F1 protein (upper panel).
###end p 89
###begin p 90
Lysates from induced and non-induced cells were incubated with GST-RB or GST-RB-K fusion proteins immobilized on glutathione-Sepharose, and the bound fraction analyzed by immunoblotting with anti-E2F1 (lower panel).
###end p 90
###begin p 91
D) Co-immunoprecipitation assay.
###end p 91
###begin p 92
###xml 22 26 22 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Phillips1">[21]</xref>
SAOS-2-tet-E2F1 cells [21] were infected with recombinant adenoviruses encoding GFP, RB, RB-K, RB-N or RB-KN and then cultured without tetracycline to induce the expression of E2F1.
###end p 92
###begin p 93
Co-immunoprecipitation of E2F1 in anti-RB immune complex was determined by immunblotting with anti-E2F1 antibody (alpha-E2F1). E) Luciferase assay.
###end p 93
###begin p 94
The Gal4-Luc reporter plasmid contains a firefly luciferase expression cassette with five Gal4 binding sequence motifs.
###end p 94
###begin p 95
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Flemington1">[22]</xref>
The Gal4-E2F1 protein contains the Gal4-DNA binding domain and the transactivation domain of E2F1 [22].
###end p 95
###begin p 96
SAOS-2 cells were transfected with Gal4-Luc and Gal4-E2F1 plasmids in the presence or absence of RB or RB-K.
###end p 96
###begin p 97
A plasmid expressing Renilla luciferase from the thymidine kinase promoter was included in the transfections for normalization of transfection efficiency.
###end p 97
###begin p 98
The firefly and Renilla luciferase activities were measured in each sample, the ratio of which was compared among the different transfections with that from the Gal4-Luc only transfected sample as the baseline.
###end p 98
###begin p 99
The values shown are averages and standard errors from three independent experiments.
###end p 99
###begin title 100
A) Transcription repression.
###end title 100
###begin p 101
###xml 4 16 4 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyclin A-Luc</italic>
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cyclin A</italic>
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000082-Strobeck1">[24]</xref>
###xml 118 123 <span type="species:ncbi:9606">human</span>
The Cyclin A-Luc reporter plasmid contains a firefly luciferase expression cassette preceded with a fragment from the human Cyclin A promoter containing E2F-binding site [24].
###end p 101
###begin p 102
The reporter was transfected into SAOS-2 cells with the indicated RB expression plasmid and the control Renilla luciferase reporter.
###end p 102
###begin p 103
The normalized firefly luciferase activity from vector co-transfected cells was set at 100%.
###end p 103
###begin p 104
B) GST pull-down assay.
###end p 104
###begin p 105
Lysates from 293T cells expressing HA-tagged E2F1 and DP1 were incubated with the indicated GST-RB and GST-E7 proteins immobilized on glutathione Sepharose.
###end p 105
###begin p 106
The HA-E2F1 in the bound fraction was resolved by SDS-PAGE and detected by immunoblotting with an anti-HA antibody (alpha-HA).
###end p 106
###begin p 107
C) Co-immunoprecipitation. The RB-deficient C33A cells were co-transfected with HA-E2F1, DP1 and the indicated RB expression plasmids.
###end p 107
###begin p 108
Whole cell lysates were incubated with anti-RB antibody (alpha-RB), and the co-immunoprecipitated E2F1 examined by immunoblotting with an anti-HA antibody (alpha-HA).
###end p 108
###begin p 109
D) GST-pull down assay with E2F3.
###end p 109
###begin p 110
Lysates from 293T cells expressing HA-tagged E2F3 and DP1 were incubated with the indicated GST-RB and GST-E7 proteins immobilized on glutathione Separose.
###end p 110
###begin p 111
The amount of E2F3 in the bound fraction was determined by immunoblotting with anti-HA antibody (alpha-HA).
###end p 111
###begin title 112
A) BrdU incorporation.
###end title 112
###begin p 113
MDA-MB468 cells were infected with the indicated recombinant adenoviruses encoding each of the indicated proteins.
###end p 113
###begin p 114
Infected cells were allowed to incorporate BrdU over a period of 14 hours before they were fixed and stained with phycoerythrin (PE)-conjugated monoclonal antibody against BrdU.
###end p 114
###begin p 115
The fraction of BrdU-positive cells in each sample was measured by flow cytometry (FACS).
###end p 115
###begin p 116
###xml 115 116 115 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
The levels of BrdU incorporation in GFP-virus and RB-KN-virus infected cells were statistically similar by student t-test (*) from three independent experiments.
###end p 116
###begin p 117
Representative FACS profiles with the BrdU-positive gates shown are displayed to the right of the histogram.
###end p 117
###begin p 118
B) Flat cell formation. SAOS-2 cells transfected with plasmids expressing neomycin resistance and each of the indicated RB proteins were cultured in G418 for two weeks.
###end p 118
###begin p 119
The giant flat cells were stained with crystal violet and their numbers counted under a dissection microscope.
###end p 119
###begin p 120
The number of flat cells induced by RB in each of four independent experiments was set at 100%.
###end p 120
###begin p 121
The means and standard errors of relative flat cell induced by vector, RB-K, RB-N and RB-KN from four experiments are shown.
###end p 121
###begin p 122
###xml 8 9 8 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Student t-test showed the number of flat cells found in RB-KN-transfected cultures was significantly different (* p<0.002) from that in RB-transfected cultures.
###end p 122
###begin title 123
A) Etoposide-induced DNA fragmentation in MDA-MB468 cells.
###end title 123
###begin p 124
Cells were infected with recombinant adenovirus expressing the indicated proteins.
###end p 124
###begin p 125
Infected cells were treated with 50 microM etoposide or vehicle control for 24 hr, fixed, stained with propidium iodide and DNA fragmentation (sub-G1 DNA content) measured by FACS.
###end p 125
###begin p 126
B) Etoposide-induced DNA fragmentation in SAOS-2 cells.
###end p 126
###begin p 127
The same experiment as in (A) except the duration of drug treatment was for 48 hours.
###end p 127
###begin p 128
###xml 32 33 32 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
C) Etoposide-induced cytochrome c release.
###end p 128
###begin p 129
MDA-MB468 cells infected with the indicated recombinant adenovirus treated with 50 microM etoposide or vehicle control.
###end p 129
###begin p 130
At 9 hours after drug addition, cells were homogenized and the mitochondria were separated from the cytosolic fraction by centrifugation.
###end p 130
###begin p 131
###xml 25 26 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
The levels of cytochrome c in the post-mitochondrial supernatants were determined by immunoblotting.
###end p 131
###begin p 132
D) Etoposide-induced caspase 3 cleavage. MDA-MB468 cells infected with the indicated recombinant adenovirus were treated with 50 microM etoposide.
###end p 132
###begin p 133
Cells were harvested at the indicated time points and the levels of cleaved caspase-3 determined by immunoblotting with antibodies specific to the cleaved caspase-3.
###end p 133
###begin title 134
A) RB phosphorylation by Cdk2/Cyclin E in SAOS-2 cells.
###end title 134
###begin p 135
Cells were infected with recombinant adenovirus expressing RB or RB-KN, in the absence or presence of co-infection with recombinant adenovirus expressing Cdk2 and Cyclin E.
###end p 135
###begin p 136
The electrophoresis mobility of RB was examined by immunoblotting of whole cell lysates with anti-RB.
###end p 136
###begin p 137
B) Representative FACS profiles. SAOS-2 cells infected with the indicated recombinant adenoviruses were treated with 50 microM etoposide, harvested 48 hours later, fixed, stained with propidium iodide and the DNA content analyzed by FACS.
###end p 137
###begin p 138
The gate for sub-G1 DNA fraction is shown in each profile.
###end p 138
###begin p 139
C) Summary of DNA fragmentation results.
###end p 139
###begin p 140
The sub-G1 DNA content was determined by FACS analysis as illustrated in panel B.
###end p 140
###begin p 141
The values are mean and standard errors from three independent experiments.
###end p 141
###begin p 142
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 142
###begin p 143
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: NIH-NCI (USA) CA58320 to JYJW; Damon Runyon Medical Research Foundation Postdoctoral Fellowship (BNC)
###end p 143

